These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 33229323)

  • 1. [Progress on signal pathways related to bone metabolism in animals].
    Zhao JY; Duan XH; Wang QT; Huang Y; Jia JJ; Dou TF
    Yi Chuan; 2020 Oct; 42(10):979-992. PubMed ID: 33229323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radix Salviae miltiorrhizae improves bone microstructure and strength through Wnt/β-catenin and osteoprotegerin/receptor activator for nuclear factor-κB ligand/cathepsin K signaling in ovariectomized rats.
    Liu H; Zhu R; Wang L; Liu C; Ma R; Qi B; Chen B; Li L; Guo Y; Shi S; Jia Q; Niu J; Zhao D; Mo F; Gao S; Zhang D
    Phytother Res; 2018 Dec; 32(12):2487-2500. PubMed ID: 30306652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in bone cell biology.
    Hofbauer LC; Heufelder AE
    J Mol Med (Berl); 2001 Jun; 79(5-6):243-53. PubMed ID: 11485016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoblasts provide a suitable microenvironment for the action of receptor activator of nuclear factor-kappaB ligand.
    Yamamoto Y; Udagawa N; Matsuura S; Nakamichi Y; Horiuchi H; Hosoya A; Nakamura M; Ozawa H; Takaoka K; Penninger JM; Noguchi T; Takahashi N
    Endocrinology; 2006 Jul; 147(7):3366-74. PubMed ID: 16627581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of interleukin-17 on nitric oxide production and osteoclastic bone resorption: is there dependency on nuclear factor-kappaB and receptor activator of nuclear factor kappaB (RANK)/RANK ligand signaling?
    Van Bezooijen RL; Papapoulos SE; Löwik CW
    Bone; 2001 Apr; 28(4):378-86. PubMed ID: 11336918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights on biology and pathology of HIF-1α/-2α, TGFβ/BMP, Wnt/β-catenin, and NF-κB pathways in osteoarthritis.
    Wu L; Huang X; Li L; Huang H; Xu R; Luyten W
    Curr Pharm Des; 2012; 18(22):3293-312. PubMed ID: 22646092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smad4 is required for maintaining normal murine postnatal bone homeostasis.
    Tan X; Weng T; Zhang J; Wang J; Li W; Wan H; Lan Y; Cheng X; Hou N; Liu H; Ding J; Lin F; Yang R; Gao X; Chen D; Yang X
    J Cell Sci; 2007 Jul; 120(Pt 13):2162-70. PubMed ID: 17550966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin, bone regulation and the ubiquitin-proteasome connection: A review.
    Vriend J; Reiter RJ
    Life Sci; 2016 Jan; 145():152-60. PubMed ID: 26706287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-20 differentially regulates bone mesenchymal stem cell activities in RANKL-induced osteoclastogenesis through the OPG/RANKL/RANK axis and the NF-κB, MAPK and AKT signalling pathways.
    Meng B; Wu D; Cheng Y; Huang P; Liu Y; Gan L; Liu C; Cao Y
    Scand J Immunol; 2020 May; 91(5):e12874. PubMed ID: 32090353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skeletal changes in osteoprotegerin and receptor activator of nuclear factor-kappab ligand mRNA levels in primary hyperparathyroidism: effect of parathyroidectomy and association with bone metabolism.
    Stilgren LS; Rettmer E; Eriksen EF; Hegedüs L; Beck-Nielsen H; Abrahamsen B
    Bone; 2004 Jul; 35(1):256-65. PubMed ID: 15207766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression profiles of receptor activator of nuclear factor kappaB ligand, receptor activator of nuclear factor kappaB, and osteoprotegerin messenger RNA in aged and ovariectomized rat bones.
    Ikeda T; Utsuyama M; Hirokawa K
    J Bone Miner Res; 2001 Aug; 16(8):1416-25. PubMed ID: 11499864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone morphogenetic protein-2 enhances Wnt/beta-catenin signaling-induced osteoprotegerin expression.
    Sato MM; Nakashima A; Nashimoto M; Yawaka Y; Tamura M
    Genes Cells; 2009 Feb; 14(2):141-53. PubMed ID: 19170762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulsed electromagnetic fields modulate bone metabolism via RANKL/OPG and Wnt/β-catenin pathways in women with postmenopausal osteoporosis: A pilot study.
    Catalano A; Loddo S; Bellone F; Pecora C; Lasco A; Morabito N
    Bone; 2018 Nov; 116():42-46. PubMed ID: 30010081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae.
    Palmqvist P; Persson E; Conaway HH; Lerner UH
    J Immunol; 2002 Sep; 169(6):3353-62. PubMed ID: 12218157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor activator of nuclear factor-κB ligand (RANKL)/RANK/osteoprotegerin system in bone and other tissues (review).
    Liu W; Zhang X
    Mol Med Rep; 2015 May; 11(5):3212-8. PubMed ID: 25572286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of zinc supplementation against cadmium-induced oxidative stress and the RANK/RANKL/OPG system imbalance in the bone tissue of rats.
    Brzóska MM; Rogalska J
    Toxicol Appl Pharmacol; 2013 Oct; 272(1):208-20. PubMed ID: 23726800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoid regulation of osteoclast differentiation and expression of receptor activator of nuclear factor-kappaB (NF-kappaB) ligand, osteoprotegerin, and receptor activator of NF-kappaB in mouse calvarial bones.
    Swanson C; Lorentzon M; Conaway HH; Lerner UH
    Endocrinology; 2006 Jul; 147(7):3613-22. PubMed ID: 16614077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of dietary calcium to available phosphorus ratios on bone metabolism and osteoclast activity of the OPG /RANK/RANKL signalling pathway in piglets.
    Zhao L; Li M; Sun H
    J Anim Physiol Anim Nutr (Berl); 2019 Jul; 103(4):1224-1232. PubMed ID: 31062421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoprotegerin regulates bone formation through a coupling mechanism with bone resorption.
    Nakamura M; Udagawa N; Matsuura S; Mogi M; Nakamura H; Horiuchi H; Saito N; Hiraoka BY; Kobayashi Y; Takaoka K; Ozawa H; Miyazawa H; Takahashi N
    Endocrinology; 2003 Dec; 144(12):5441-9. PubMed ID: 14500574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing.
    Kon T; Cho TJ; Aizawa T; Yamazaki M; Nooh N; Graves D; Gerstenfeld LC; Einhorn TA
    J Bone Miner Res; 2001 Jun; 16(6):1004-14. PubMed ID: 11393777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.